Search details
1.
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
BJU Int
; 133(3): 297-304, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37548533
2.
Race/Ethnicity and Gender Representation in Hematology and Oncology Editorial Boards: What is the State of Diversity?
Oncologist
; 28(7): 609-617, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37119268
3.
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
Oncologist
; 28(9): e748-e755, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-36971500
4.
Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma.
Oncologist
; 28(12): 1079-1084, 2023 Dec 11.
Article
in English
| MEDLINE | ID: mdl-37432304
5.
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study.
Cancer Invest
; 41(1): 70-76, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36239609
6.
Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status.
Cancer
; 127(3): 354-358, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-33007114
7.
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Cancer
; 126(11): 2597-2606, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32208524
8.
Reliability and validity of the Turkish version of the Diabetes Distress Scale for type 2 diabetes and distress levels of the participants
Turk J Med Sci
; 50(2): 464-470, 2020 04 09.
Article
in English
| MEDLINE | ID: mdl-31655535
9.
Biopsychosocial distress and clinical outcome in metastatic renal cell carcinoma.
Palliat Support Care
; 17(3): 353-355, 2019 06.
Article
in English
| MEDLINE | ID: mdl-29911518
10.
Assessment of distress and quality of life in rare cancers.
Psychooncology
; 27(12): 2740-2746, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30171792
11.
Adjuvant treatment in renal cell carcinoma.
Clin Adv Hematol Oncol
; 16(8): 555-563, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-30148828
12.
Immune checkpoint inhibitors and timing of administration.
Lancet Oncol
; 23(2): e56, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35114125
13.
Advances in treatment of metastatic renal cell carcinoma.
Curr Opin Urol
; 26(5): 439-46, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27467136
14.
Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances.
Am Soc Clin Oncol Educ Book
; 44(3): e438642, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38776514
15.
Barriers to Clinical Trial Implementation Among Community Care Centers.
JAMA Netw Open
; 7(4): e248739, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38683608
16.
Outcomes With Combination Pembrolizumab and Axitinib in Second and Further Line Treatment of Metastatic Renal Cell Carcinoma.
Clin Genitourin Cancer
; 21(2): 221-229, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36681606
17.
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Clin Genitourin Cancer
; 21(1): 69-75, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36509613
18.
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.
Front Immunol
; 14: 1274781, 2023.
Article
in English
| MEDLINE | ID: mdl-38259453
19.
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma.
Clin Genitourin Cancer
; 21(1): 55-62, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36411184
20.
Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma.
JCO Precis Oncol
; 7: e2200543, 2023 04.
Article
in English
| MEDLINE | ID: mdl-37027813